Oct 13, 2020 - Dr. Zachery Halford, Dr. Mary Kate Anderson ('20) and Dr. Matt Clark ('18) published Enfortumab Vedotin-ejfv: A First-in-Class Anti–Nectin-4 Antibody-Drug Conjugate for the Management of Urothelial Carcinoma in Annals of Pharmacotherapy.
Dr. Zachery Halford
Dr. Mary Kate Anderson
Dr. Matt Clark